North Star Investment Management’s Niagen Bioscience NAGE Stock Holding History

North Star Investment Management’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.9K	Hold	5,000	–	–	﹤0.01%	967
2026 Q1	$22.1K	Hold	5,000	–	–	﹤0.01%	882
2025 Q4	$31.8K	Hold	5,000	–	–	﹤0.01%	764
2025 Q3	$46.6K	Hold	5,000	–	–	﹤0.01%	669
2025 Q2	$72K	Hold	5,000	–	–	0.01%	577
2025 Q1	$34.5K	Hold	5,000	–	–	﹤0.01%	679
2024 Q4	$26.5K	Hold	5,000	–	–	﹤0.01%	722
2024 Q3	$18.3K	Hold	5,000	–	–	﹤0.01%	743
2024 Q2	$13.7K	Hold	5,000	–	–	﹤0.01%	772
2024 Q1	$17.4K	Hold	5,000	–	–	﹤0.01%	769
2023 Q4	$7.15K	Hold	5,000	–	–	﹤0.01%	889
2023 Q3	$7.3K	Hold	5,000	–	–	﹤0.01%	893
2023 Q2	$7.85K	Hold	5,000	–	–	﹤0.01%	900
2023 Q1	$7.65K	Hold	5,000	–	–	﹤0.01%	916
2022 Q4	$8.4K	Sell	5,000 -13,000	-72%	-$20.6K	﹤0.01%	881
2022 Q3	$22K	Hold	18,000	–	–	﹤0.01%	686
2022 Q2	$30K	Hold	18,000	–	–	﹤0.01%	650
2022 Q1	$44K	Hold	18,000	–	–	﹤0.01%	611
2021 Q4	$67K	Hold	18,000	–	–	﹤0.01%	555
2021 Q3	$113K	Hold	18,000	–	–	0.01%	457
2021 Q2	$177K	Sell	18,000 -4,167	-19%	-$36.3K	0.01%	398
2021 Q1	$207K	Hold	22,167	–	–	0.02%	359
2020 Q4	$106K	Hold	22,167	–	–	0.01%	429
2020 Q3	$89K	Hold	22,167	–	–	0.01%	426
2020 Q2	$102K	Hold	22,167	–	–	0.01%	393
2020 Q1	$72K	Hold	22,167	–	–	0.01%	432
2019 Q4	$96K	Hold	22,167	–	–	0.01%	442
2019 Q3	$87K	Hold	22,167	–	–	0.01%	447
2019 Q2	$103K	Sell	22,167 -15,901	-42%	-$67.8K	0.01%	381
2019 Q1	$160K	Hold	38,068	–	–	0.02%	383
2018 Q4	$131K	Hold	38,068	–	–	0.02%	382
2018 Q3	$163K	Sell	38,068 -35,266	-48%	-$152K	0.02%	375
2018 Q2	$272K	Sell	73,334 -35,000	-32%	-$133K	0.03%	324
2018 Q1	$455K	Sell	108,334 -45,000	-29%	-$236K	0.05%	269
2017 Q4	$902K	Sell	153,334 -85,866	-36%	-$464K	0.11%	203
2017 Q3	$1.03M	Sell	239,200 -26,134	-10%	-$95.5K	0.13%	183
2017 Q2	$1.01M	Buy	265,334 +117,000	+79%	+$371K	0.14%	171
2017 Q1	$399K	Sell	148,334 -60,000	-29%	-$170K	0.05%	265
2016 Q4	$690K	Sell	208,334 -63,334	-23%	-$172K	0.1%	203
2016 Q3	$810K	Buy	+271,668	New	+$997K	0.14%	170

Other funds holding NAGE

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

AWM

Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return

MGI

Miller Global Investments Dallas, Texas $121M AUM

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

North Star Investment Management's NAGE Position: Q2 2026 in Review

North Star Investment Management held its Niagen Bioscience (NAGE) position steady in Q2 2026 at 5,000 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #967.

North Star Investment Management first reported a position in NAGE in Q3 2016 and has held it in 40 quarters since. The position peaked at $1.03M in Q3 2017. 23 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

North Star Investment Management held 5,000 shares of Niagen Bioscience worth $15.9K as of Q2 2026.
North Star Investment Management left its Niagen Bioscience share count unchanged in Q2 2026.
Niagen Bioscience made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #967 holding.
North Star Investment Management first reported a position in Niagen Bioscience in Q3 2016 and has held it in 40 quarters since.
North Star Investment Management's Niagen Bioscience position peaked at $1.03M in Q3 2017.
23 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.